• Issue

    Inflammatory Bowel Diseases: Volume 13, Issue 1

    1-121
    January 2007
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Editorial

Editorial

Robert Burakoff MD,  Richard MacDermott MD,  Marjorie Merrick, 
  • Page: 1
  • First Published: 19 December 2006

Original Articles

Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab

Bruce E. Sands MD, MS,  Richard Kozarek MD,  Jack Spainhour MD,  Charles F. Barish MD,  Scott Becker MD,  Lawrence Goldberg MD,  Seymour Katz MD,  Ronald Goldblum MD,  Rena Harrigan MPH,  Deborah Hilton MS,  Stephen B. Hanauer MD, 
  • Pages: 2-11
  • First Published: 19 December 2006

Original Clinical Articles

Does colonoscopy cause increased ulcerative colitis symptoms?

Stacy Menees MD,  Peter Higgins MD,  Sheryl Korsnes MA,  Grace Elta MD, 
  • Pages: 12-18
  • First Published: 19 December 2006

Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine a in patients with steroid resistant ulcerative colitis†

Fady Daniel MD,  Marie-Anne Loriot MD,  Philippe Seksik MD,  Jacques Cosnes MD, PhD,  Jean-Marc Gornet MD,  Marc Lémann MD, PhD,  Francine Fein MD,  Gwenola Vernier-Massouille MD,  Martine De Vos MD, PhD,  Arnaud Boureille MD,  Xavier Treton MD,  Bernard Flourié MD, PhD,  Xavier Roblin MD, PhD,  Edouard Louis MD, PhD,  Frank Zerbib MD, PhD,  Philippe Beaune MD, PhD,  Philippe Marteau MD, PhD, 
  • Pages: 19-23
  • First Published: 19 December 2006

The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients

Lene Riis MD, PhD,  Ida Vind,  Severine Vermeire,  Frank Wolters,  Kostas Katsanos,  Patrizia Politi,  João Freitas,  Ioannis A. Mouzas,  Colm O'Morain,  Victor Ruiz-Ochoa,  Selwyn Odes,  Vibeke Binder,  Pia Munkholm,  Bjørn Moum,  Reinhold Stockbrügger,  Ebbe Langholz, 
  • Pages: 24-32
  • First Published: 19 December 2006

The Luebeck interview for psychosocial screening in patients with inflammatory bowel disease

S. Kunzendorf MD,  G. Jantschek MD,  K. Straubinger MD,  I. Heberlein MD, PhD,  N. Homann MD,  D. Ludwig MD,  D. Benninghoven PhD, 
  • Pages: 33-41
  • First Published: 19 December 2006

Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease

Francisco A. Sylvester,  Nancy Wyzga,  Jeffrey S. Hyams,  Patricia M. Davis,  Trudy Lerer,  Katherine Vance,  Gillian Hawker,  Anne M. Griffiths, 
  • Pages: 42-50
  • First Published: 19 December 2006

Original Basic Science Articles

Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis

Alexander Swidsinski,  Vera Loening-Baucke,  Stig Bengmark,  Herbert Lochs,  Yvonne Dörffel, 
  • Pages: 51-56
  • First Published: 19 December 2006

Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease

Gabriele Stocco PhD,  Stefano Martelossi MD,  Arrigo Barabino MD,  Giuliana Decorti MD,  Fiora Bartoli MD,  Marcella Montico,  Annalisa Gotti,  Alessandro Ventura MD, 
  • Pages: 57-64
  • First Published: 19 December 2006

Predictive value of mucosal TNF-α transcripts in steroid-refractory Crohn's disease patients receiving intensive immunosuppressive therapy

Carsten Schmidt,  Thomas Giese,  Eva Hermann,  Stefan Zeuzem,  Stefan C. Meuer,  Andreas Stallmach, 
  • Pages: 65-70
  • First Published: 19 December 2006

Macrophage migration inhibitory factor (MIF) −173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease

Julia Dambacher,  Tanja Staudinger,  Julia Seiderer MD,  Zeljka Sisic,  Fabian Schnitzler MD,  Simone Pfennig,  Katrin Hofbauer,  Astrid Konrad MD,  Cornelia Tillack MD,  Jan-Michel Otte MD,  Joachim Diebold MD,  Burkhard Göke MD,  Thomas Ochsenkühn MD,  Peter Lohse MD,  Stephan Brand MD, 
  • Pages: 71-82
  • First Published: 19 December 2006

Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells

Julia-Stefanie Frick MD,  Katrin Schenk,  Matteo Quitadamo,  Frauke Kahl,  Martin Köberle,  Erwin Bohn PhD,  Martin Aepfelbacher MD,  Ingo B. Autenrieth MD, 
  • Pages: 83-90
  • First Published: 19 December 2006

Clinical Viewpoint

Treatment of irritable bowel syndrome in outpatients with inflammatory bowel disease using a food and beverage intolerance, food and beverage avoidance diet

Richard P. MacDermott MD, 
  • Pages: 91-96
  • First Published: 19 December 2006

Basic Science Review

Matrix metalloproteinases in inflammatory bowel disease: Boon or a bane?

Anupama Ravi MD,  Pallavi Garg PhD,  Shanthi V. Sitaraman MD, PhD, 
  • Pages: 97-107
  • First Published: 19 December 2006

Clinical Review

Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis

Victoria E. McGilligan,  Julie M. W. Wallace,  Patricia M. Heavey,  Diana L. Ridley,  Ian R. Rowland, 
  • Pages: 108-115
  • First Published: 19 December 2006

Selected Summaries

Why good pouches go bad

Elizabeth Hait MD,  Paul A. Rufo MD, MMSc, 
  • Pages: 116-117
  • First Published: 19 December 2006

Letters to the Editor

Synergistic effect of methotrexate and infliximab on activated lymphocyte apoptosis

Jan M.H van den Brande MD,  Maikel P. Peppelenbosch PhD,  Daan W. Hommes MD, PhD, 
  • Pages: 118-119
  • First Published: 19 December 2006

Litaf/Simple protein is increased in intestinal tissues from patients with CD and UC, but is unlikely to function as a transcription factor

Yongzhao Huang,  Craig L. Bennett, 
  • Pages: 120-121
  • First Published: 19 December 2006